News – USA – Premarket Mover: Citius Pharmaceuticals Inc (CTXR) Up 1505%


CTXR has a strong 96 total, meaning the stock holds a better value than 96% of the stock at its current price. InvestorsObserver’s overall ranking system is a comprehensive assessment and takes into account both technical and fundamental factors When Evaluating a Stock Total Score is a good place to start for investors starting out by evaluating a stock
CTXR receives an average short-term technical score of 60 from InvestorsObserver’s proprietary ranking system, meaning the stock’s trading pattern has been neutral over the past month, and Citius Pharmaceuticals Inc currently ranks 85th Highest Short-Term Technical Score in the Biotechnology Industry The Short-Term Technical Score measures a stock’s trading pattern over the past month and is most useful for short-term stock and options traders
Citius Pharmaceuticals Inc’s general and short-term technical score provides a strong picture of recent trading patterns and the forecast price of CTXR
For the full Stock Score Report on Citius Pharmaceuticals Inc (CTXR) Stocks, click here

Subscribe to our daily morning update newsletter and don’t miss the important market news, moves, and more

Copyright © 2021 Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer and / or O2 Media LLC All rights reserved Portions of this content are protected by U.S. Patents No. 7,865,496, 7,856,390 and 7,716,116 protected Investments in stocks, bonds, options and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and are based on different expiration dates in the Investment Terms of Use | Privacy policy

Citius Pharmaceuticals, NASDAQ: CTXR, Nasdaq, Stock, Pharmaceutical Industry

News – USA – Premarket Mover: Citius Pharmaceuticals Inc (CTXR) Up 1505%
Related Title :
CTXR share price rises above 10% Pre-Market: Why it happened
Premarket Mover: Citius Pharmaceuticals Inc (CTXR) Up to 1505%
Technical data drives growth: Citius Pharmaceuticals Inc (CTXR), Birks Group Inc (BGI)
> What does Citius Pharma expect in 2021?